LINC01948: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01948

NCBI ID: G102467147

LINC01948

Other Name(s): long intergenic non-protein coding RNA 1948 | Long intergenic non-protein coding RNA 1948

LINC01948: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01948 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells, including brain, heart, and muscle. The function and regulation of LINC01948 are not well understood, but its potential involvement in disease processes has led to a growing interest in its study as a potential drug target.

Drug Target Potential

LINC01948 has been identified as a potential drug target due to its unique structure and expression pattern. It is a long RNA molecule that contains a highly conserved open reading frame (ORF) at its start, which is typically a protein-coding region. However, unlike most proteins, LINC01948 does not contain a protein coding region. Instead, it has a unique mechanism of regulation that involves a covalent interaction with a protein called RNA-protein interaction (RNA-PIP) complex.

The RNA-PIP complex is a protein-protein interaction that is composed of two subunits, RP1 and RP2. These subunits have been shown to interact with various RNA molecules, including LINC01948. The interaction between RP1 and LINC01948 has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and protein translation.

In addition to its potential role in cellular processes, LINC01948 has also been shown to interact with proteins that are involved in diseases, including cancer and neurodegenerative diseases. For example, studies have shown that LINC01948 interacts with the protein known as heat shock protein (HSP70), which is involved in the regulation of cellular stress responses.

Biomarker Potential

LINC01948 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is due to its expression pattern, which is often altered in these diseases. Studies have shown that LINC01948 is expressed in a variety of tissues and cells, including cancer cells, neurodegenerative disease mouse models, and cardiovascular disease patient samples.

In addition to its expression, LINC01948 has also been shown to play a role in the regulation of cellular processes that are involved in disease development. For example, studies have shown that LINC01948 is involved in the regulation of cellular signaling pathways that are involved in cancer progression, neurodegenerative disease, and cardiovascular disease.

Conclusion

In conclusion, LINC01948 is a long intergenic non-protein-coding RNA that has the potential to be a drug target and biomarker. Its unique structure and regulation, as well as its potential involvement in disease processes, make it an attractive target for further study. Further research is needed to fully understand the function and regulation of LINC01948, as well as its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1948

The "LINC01948 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01948 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets